Reproducibility of PET studies with L-[β-11C]DOPA and [18F]FE-PE2I in healthy humans

被引：0
|
作者：
Suzuki, Masayuki [1 ]
Ito, Hiroshi [1 ]
Takano, Harumasa [1 ]
Fujiwara, Hironobu [1 ]
Kimura, Yasuyuki [1 ]
Kodaka, Fumitoshi [1 ]
Varrene, Andrea [2 ]
Okubo, Yoshiro [3 ]
Suhara, Tetsuya [1 ]
机构：
[1] Natl Inst Radiol Sci, Mol Neuroimaging Program, Mol Imaging Ctr, Chiba 260, Japan
[2] Karolinska Inst, Karolinska Hosp, Dept Clin Neurosci, Ctr Psychiat Res, S-10401 Stockholm, Sweden
[3] Nippon Med Sch, Dept Neuropsychiat, Tokyo 113, Japan
来源：
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 2012年 / 32卷
关键词：
BRAIN;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S131 / S131
页数：1
相关论文
共 50 条
  • [31] In Vitro Autoradiography and In Vivo Evaluation in Cynomolgus Monkey of [18F]FE-PE2I, a New Dopamine Transporter PET Radioligand
    Varrone, Andrea
    Steiger, Carsten
    Schou, Magnus
    Takano, Akihiro
    Finnema, Sjoerd. J.
    Guilloteau, Denis
    Gulyas, Balazs
    Halldin, Christer
    SYNAPSE, 2009, 63 (10) : 871 - 880
  • [32] Striatal Presynaptic Dopamine in Schizophrenia, Part II: Meta-Analysis of [18F/11C]-DOPA PET Studies
    Fusar-Poli, Paolo
    Meyer-Lindenberg, Andreas
    SCHIZOPHRENIA BULLETIN, 2013, 39 (01) : 33 - 42
  • [33] Combination of the 11C Raclopride pet with 18F FDG PET to predict the therapeutic effect of L-DOPA on the Parkinsonian patients.
    Makoto, N
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 226P - 226P
  • [34] Evaluation of tryptophan derivative, [18F]trifluoromethyl-L-tryptophan ([18F]CF3-L-Trp) as PET/MR agent for detection of prostate cancer: Comparison with L-[11C]Methionine ([11C]MET)
    Kim, Ho Young
    Lee, Ji Youn
    Seo, Hyeyeon
    Lee, Yun-Sang
    Jeong, Jae Min
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S499 - S500
  • [35] Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECT—a clinical comparison
    Susanna Jakobson Mo
    Jan Axelsson
    Lars Jonasson
    Anne Larsson
    Mattias J. Ögren
    Margareta Ögren
    Andrea Varrone
    Linda Eriksson
    David Bäckström
    Sara af Bjerkén
    Jan Linder
    Katrine Riklund
    EJNMMI Research, 8
  • [36] Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECTa clinical comparison
    Mo, Susanna Jakobson
    Axelsson, Jan
    Jonasson, Lars
    Larsson, Anne
    Ogren, Mattias J.
    Ogren, Margareta
    Varrone, Andrea
    Eriksson, Linda
    Backstrom, David
    af Bjerken, Sara
    Linder, Jan
    Riklund, Katrine
    EJNMMI RESEARCH, 2018, 8
  • [37] Quantitative analysis of [18F]FE-PE2I binding to the dopamine transporter in Parkinson's disease
    Fazio, Patrik
    Svenningsson, Per
    Forsberg, Anton
    Jonsson, Erik
    Amini, Nahid
    Nakao, Ryuji
    Halldin, Christer
    Farde, Lars
    Varrone, Andrea
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [38] Age-related decline in dopamine transporter in human brain using PET with a new radioligand [18F]FE-PE2I
    Shingai, Yoshitoshi
    Tateno, Amane
    Arakawa, Ryosuke
    Sakayori, Takeshi
    Kim, WooChan
    Suzuki, Hidenori
    Okubo, Yoshiro
    ANNALS OF NUCLEAR MEDICINE, 2014, 28 (03) : 220 - 226
  • [39] Age-related decline in dopamine transporter in human brain using PET with a new radioligand [18F]FE-PE2I
    Yoshitoshi Shingai
    Amane Tateno
    Ryosuke Arakawa
    Takeshi Sakayori
    WooChan Kim
    Hidenori Suzuki
    Yoshiro Okubo
    Annals of Nuclear Medicine, 2014, 28 : 220 - 226
  • [40] Initial Evaluation of the Novel Dopamine Transporter Radioligand [18F]FE-PE2I in Healthy Controls and Parkinson's Disease Patients
    Varrone, A.
    Forsberg, A.
    Nakao, R.
    Amini, N.
    Nag, S.
    Svenningsson, P.
    Halldin, C.
    Farde, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S182 - S182
12345